Clinical trials: Mesial Temporal Lobe Epilepsy With Hippocampal Sclerosis, open to volunteers
Mesial Temporal Lobe Epilepsy
AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy
The main goals of this clinical study are to learn if AMT-260 is safe and tolerable and works to reduce the frequency of seizures in adults with unilateral mesial temporal lobe epilepsy (MTLE).
- Trial name
- GenTLE (NCT06063850)
- Testing
- AAV9-hSyn1-miGRIK2
- Where
- 18 sites in United States
- Volunteers
- 12 people
- Sponsor
- UniQure Biopharma B.V.
Mesial Temporal Lobe Epilepsy With Hippocampal Sclerosis, Epilepsy
High Selective Subiculum SEEG Guided RF-TC for mTLE-HS
The primary objective of this research is to study the efficacy and safety of Stereotactic EEG (SEEG) guided radio-frequency thermocoagulation (RF-TC) of Subiculum as adjunctive therapy for reducing the frequency of seizures in…
- Trial name
- NCT06558864
- Testing
- Subiculum RF-TC
- Volunteers
- 20 people
- Sponsor
- Xuanwu Hospital, Beijing